Literature DB >> 9843908

Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism.

C Meyer1, J Dostou, V Nadkarni, J Gerich.   

Abstract

To determine the effect of physiological hyperinsulinemia on renal and hepatic substrate metabolism, we assessed systemic and renal glucose release and uptake, systemic and renal gluconeogenesis from glutamine, and certain aspects of systemic and renal glutamine and free fatty acid (FFA) metabolism. These were assessed under basal postabsorptive conditions and during 4-h hyperinsulinemic euglycemic clamp experiments in nine normal volunteers using a combination of isotopic techniques and renal balance measurements. Hepatic glucose release (HGR) and glutamine gluconeogenesis were calculated as the difference between systemic and renal measurements. Infusion of insulin suppressed systemic glucose release and glutamine gluconeogenesis by approximately 50% during the last hour of the insulin infusion (P < 0.001). Renal glucose release and glutamine gluconeogenesis decreased from 2.3 +/- 0.4 to 0.9 +/- 0.2 (P < 0.002) and from 0.52 +/- 0.07 to 0.14 +/- 0.03 micromol. kg-1. min-1 (P < 0.001), respectively. HGR and glutamine gluconeogenesis decreased from 8.7 +/- 0.4 to 4.5 +/- 0.5 (P < 0.001) and from 0.35 +/- 0.02 to 0.27 +/- 0.03 micromol. kg-1. min-1 (P < 0.002), respectively. Renal glucose uptake (RGU) increased from 1.61 +/- 0.19 to 2.18 +/- 0.25 micromol. kg-1. min-1 (P = 0.029) but accounted for only approximately 5% of systemic glucose disposal (40.6 +/- 4.3 micromol. kg-1. min-1). Both systemic and renal FFA clearance increased approximately fourfold (P < 0.001 for both). Nevertheless, renal FFA uptake decreased (P = 0.024) and was inversely correlated with RGU (r = -0.582, P = 0.011). Finally, insulin increased systemic glutamine release (P = 0.007), uptake (P < 0.005), and clearance (P < 0.001) but left renal glutamine uptake and release unaffected (P > 0.4 for both).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843908     DOI: 10.1152/ajprenal.1998.275.6.F915

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  A fuzzy model of glucose regulation.

Authors:  Em Ward; Terry Martin
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.460

Review 2.  The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Authors:  Romana Stark; Richard G Kibbey
Journal:  Biochim Biophys Acta       Date:  2013-10-28

3.  Inhibition of NF-κB Reduces Renal Inflammation and Expression of PEPCK in Type 2 Diabetic Mice.

Authors:  Qianling Liu; Liangyan Zhang; Wei Zhang; Qiufa Hao; Wei Qiu; Yubing Wen; Haiyun Wang; Xuemei Li
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

Review 4.  Role of the kidney in hyperglycemia in type 2 diabetes.

Authors:  Christian Meyer; John E Gerich
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

5.  Characteristics of glutamine metabolism in human precision-cut kidney slices: a 13C-NMR study.

Authors:  Anne Vittorelli; Catherine Gauthier; Christian Michoudet; Guy Martin; Gabriel Baverel
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

6.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

7.  Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes.

Authors:  D Tripathy; K F Eriksson; M Orho-Melander; J Fredriksson; G Ahlqvist; L Groop
Journal:  Diabetologia       Date:  2004-04-28       Impact factor: 10.122

Review 8.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

9.  Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.

Authors:  Jie Hong; Yi-Fei Zhang; Wei-qiong Gu; Yu-wen Zhang; Yu-xia Su; Zhen-ni Chi; Wei-qing Wang; Xiao-ying Li; Guang Ning
Journal:  Endocrine       Date:  2008-11-01       Impact factor: 3.633

Review 10.  New Pandemic: Obesity and Associated Nephropathy.

Authors:  Isha Sharma; Yingjun Liao; Xiaoping Zheng; Yashpal S Kanwar
Journal:  Front Med (Lausanne)       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.